John P. Schmid - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Helix Acquisition Corp (HLXA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Helix Acquisition Corp (HLXA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Helix Acquisition Corp (HLXA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Poseida Therapeutics Inc (PSTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Poseida Therapeutics Inc (PSTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Poseida Therapeutics Inc (PSTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neos Therapeutics Inc (NEOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neos Therapeutics Inc (NEOS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neos Therapeutics Inc (NEOS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 2 insider transaction in Xeris Biopharma Holdings Inc (XERS) with a net purchase of 11,000. Other recent insider transactions involving Xeris Biopharma Holdings Inc (XERS) include a net purchase of 30,000 shares made by Paul R Edick , a net purchase of 30,769 shares made by Shannon John Patrick Jr , and a net purchase of 28,000 shares made by Steven Pieper .

In summary, during the past 3 months, insiders sold 0 shares of Xeris Biopharma Holdings Inc (XERS) in total and bought 4,500 shares, with a net purchase of 4,500 shares. During the past 18 months, 0 shares of Xeris Biopharma Holdings Inc (XERS) were sold and 110,579 shares were bought by its insiders, resulting in a net purchase of 110,579 shares.

Xeris Biopharma Holdings Inc (XERS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in AnaptysBio Inc (ANAB). Other recent insider transactions involving AnaptysBio Inc (ANAB) include a net sale of 14,187 shares made by Eric J Loumeau , a net sale of 11,245 shares made by Dennis Mulroy , and a net sale of 155,806 shares made by Daniel Faga .

In summary, during the past 3 months, insiders sold 157,005 shares of AnaptysBio Inc (ANAB) in total and bought 0 shares, with a net sale of 157,005 shares. During the past 18 months, 185,897 shares of AnaptysBio Inc (ANAB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 185,897 shares.

AnaptysBio Inc (ANAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made 1 insider transaction in Design Therapeutics Inc (DSGN) with a net purchase of 26,965. Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 36,000 shares made by Rodney W Lappe , a net purchase of 2,235,000 shares made by Arsani William , and a net purchase of 900,000 shares made by Sr One Capital Fund I Aggregator Lp .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 28,265 shares, with a net purchase of 28,265 shares. During the past 18 months, 0 shares of Design Therapeutics Inc (DSGN) were sold and 4,118,715 shares were bought by its insiders, resulting in a net purchase of 4,118,715 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, John P. Schmid made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 384,740 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 384,740 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.